Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

Open access
Sazonovs, Aleksejs, Stevens, Christine R., Venkataraman, Guhan R., Yuan, Kai, Avila, Brandon, Abreu, Maria T., Ahmad, Tariq, Allez, Matthieu, Ananthakrishnan, Ashwin N., Atzmon, Gil, Baras, Aris, Barrett, Jeffrey C., Barzilai, Nir, Beaugerie, Laurent, Beecham, Ashley, Bernstein, Charles N., Bitton, Alain, Bokemeyer, Bernd, Chan, Andrew, Chung, Daniel, Cleynen, Isabelle, Cosnes, Jacques, Cutler, David J., Daly, Allan, Damas, Oriana M., Datta, Lisa W., Dawany, Noor, Devoto, Marcella, Dodge, Sheila, Ellinghaus, Eva, Fachal, Laura, Farkkila, Martti, Faubion, William, Ferreira, Manuel, Franchimont, Denis, Gabriel, Stacey B., Ge, Tian, Georges, Michel, Gettler, Kyle, Giri, Mamta, Glaser, Benjamin, Goerg, Siegfried, Goyette, Philippe, Graham, Daniel, Hämäläinen, Eija, Haritunians, Talin, Heap, Graham A., Hiltunen, Mikko, Hoeppner, Marc, Horowitz, Julie E., Irving, Peter, Iyer, Vivek, Jalas, Chaim, Kelsen, Judith, Khalili, Hamed, Kirschner, Barbara S., Kontula, Kimmo, Koskela, Jukka T., Kugathasan, Subra, Kupcinskas, Juozas, Lamb, Christopher A., Laudes, Matthias, Lévesque, Chloé, Levine, Adam P., Lewis, James D., Liefferinckx, Claire, Loescher, Britt-Sabina, Louis, Edouard, Mansfield, John, May, Sandra, McCauley, Jacob L., Mengesha, Emebet, Mni, Myriam, Moayyedi, Paul, Moran, Christopher J., Newberry, Rodney D., O’Charoen, Sirimon, Okou, David T., Oldenburg, Bas, Ostrer, Harry, Palotie, Aarno, Paquette, Jean, Pekow, Joel, Peter, Inga, Pierik, Marieke J., Ponsioen, Cyriel Y., Pontikos, Nikolas, Prescott, Natalie, Pulver, Ann E., Rahmouni, Souad, Rice, Daniel L., Saavalainen, Päivi, Sands, Bruce, Sartor, R. Balfour, Schiff, Elena R., Schreiber, Stefan, Schumm, L. Philip, Segal, Anthony W., Seksik, Philippe, Shawky, Rasha, Sheikh, Shehzad Z., Silverberg, Mark S., Simmons, Alison, Skeiceviciene, Jurgita, Sokol, Harry, Solomonson, Matthew, Somineni, Hari, Sun, Dylan, Targan, Stephan, Turner, Dan, Uhlig, Holm H., van der Meulen, Andrea E., Vermeire, Séverine, Verstockt, Sare, Voskuil, Michiel D., Winter, Harland S., Young, Justine, Belgium IBD Consortium, Cedars-Sinai IBD, International IBD Genetics Consortium, NIDDK IBD Genetics Consortium, NIHR IBD BioResource, Regeneron Genetics Center, SHARE Consortium, SPARC IBD Network, UK IBD Genetics Consortium, Duerr, Richard H., Franke, Andre, Brant, Steven R., Cho, Judy, Weersma, Rinse K., Parkes, Miles, Xavier, Ramnik J., Rivas, Manuel A., Rioux, John D., McGovern, Dermot P. B., Huang, Hailiang, Anderson, Carl A., Daly, Mark J. · 2022 · Nature Genetics

Published version of a preprint

Abstract

Genome-wide association studies (GWASs) have identified hundreds of loci associated with Crohn's disease (CD). However, as with all complex diseases, robust identification of the genes dysregulated by noncoding variants typically driving GWAS discoveries has been challenging. Here, to complement GWASs and better define actionable biological targets, we analyzed sequence data from more than 30,000 patients with CD and 80,000 population controls. We directly implicate ten genes in general onset CD for the first time to our knowledge via association to coding variation, four of which lie within established CD GWAS loci. In nine instances, a single coding variant is significantly associated, and in the tenth, ATG4C, we see additionally a significantly increased burden of very rare coding variants in CD cases. In addition to reiterating the central role of innate and adaptive immune cells as well as autophagy in CD pathogenesis, these newly associated genes highlight the emerging role of mesenchymal cells in the development and maintenance of intestinal inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-022-01156-2

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 83

  1. Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015). · DOI · Paper page
  2. Rivas, M. A. et al. A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nat. Commun. 7, 12342 (2016). · DOI
  3. Beaudoin, M. et al. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet. 9, e1003723 (2013). · DOI · Paper page
  4. Cao, Z. et al. Ubiquitin ligase TRIM62 regulates CARD9-mediated anti-fungal immunity and intestinal inflammation. Immunity 43, 715–726 (2015). · DOI
  5. Leshchiner, E. S. et al. Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease. Proc. Natl Acad. Sci. USA 114, 11392–11397 (2017). · DOI
  6. Sivanesan, D. et al. IL23R (interleukin 23 receptor) variants protective against inflammatory bowel diseases (IBD) display loss of function due to impaired protein stability and intracellular trafficking. J. Biol. Chem. 291, 8673–8685 (2016). · DOI
  7. Mohanan, V. et al. C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science 359, 1161–1166 (2018). · DOI
  8. Zhou, W. et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat. Genet. 50, 1335–1341 (2018). · DOI · Paper page
  9. Glocker, E.-O. et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033–2045 (2009). · DOI · Paper page
  10. Liu, T., Zhang, L., Joo, D. & Sun, S.-C. NF-κB signaling in inflammation. Signal Transduct. Target. Ther. 2, 17023 (2017). · DOI · Paper page
  11. Koliaraki, V., Prados, A., Armaka, M. & Kollias, G. The mesenchymal context in inflammation, immunity and cancer. Nat. Immunol. 21, 974–982 (2020). · DOI · Paper page
  12. Kurashima, Y. et al. Mucosal mesenchymal cells: secondary barrier and peripheral educator for the gut immune system. Front. Immunol. 8, 1787 (2017). · DOI
  13. Thomson, C. A., Nibbs, R. J., McCoy, K. D. & Mowat, A. M. Immunological roles of intestinal mesenchymal cells. Immunology 160, 313–324 (2020). · DOI
  14. Koliaraki, V., Pallangyo, C. K., Greten, F. R. & Kollias, G. Mesenchymal cells in colon cancer. Gastroenterology 152, 964–979 (2017). · DOI · Paper page
  15. Li, C. & Kuemmerle, J. F. The fate of myofibroblasts during the development of fibrosis in Crohn’s disease. J. Dig. Dis. 21, 326–331 (2020). · DOI
  16. Kinchen, J. et al. Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease. Cell 175, 372–386.e17 (2018). · DOI · Paper page
  17. Shi, Y. et al. PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells. J. Biol. Chem. 295, 13798–13811 (2020). · DOI
  18. Maier, J. I. et al. EPB41L5 controls podocyte extracellular matrix assembly by adhesome-dependent force transmission. Cell Rep. 34, 108883 (2021). · DOI
  19. Yuda, A., Lee, W. S., Petrovic, P. & McCulloch, C. A. Novel proteins that regulate cell extension formation in fibroblasts. Exp. Cell. Res. 365, 85–96 (2018). · DOI
  20. Pompili, S., Latella, G., Gaudio, E., Sferra, R. & Vetuschi, A. The charming world of the extracellular matrix: a dynamic and protective network of the intestinal wall. Front. Med. 8, 610189 (2021). · DOI
  21. Martin, J. C. et al. Single-cell analysis of Crohn’s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy. Cell 178, 1493–1508.e20 (2019). · DOI · Paper page
  22. Treveil, A. et al. Regulatory network analysis of Paneth cell and goblet cell enriched gut organoids using transcriptomics approaches. Mol. Omics 16, 39–58 (2020). · DOI
  23. Kaser, A. & Blumberg, R. S. Endoplasmic reticulum stress in the intestinal epithelium and inflammatory bowel disease. Semin. Immunol. 21, 156–163 (2009). · DOI
  24. Zhang, M. & Wu, C. The relationship between intestinal goblet cells and the immune response. Biosci. Rep. 40, BSR20201471 (2020). · DOI
  25. Wang, X. et al. Function and dysfunction of plasma cells in intestine. Cell Biosci. 9, 26 (2019). · DOI
  26. Boucher, G. et al. Serum analyte profiles associated with Crohn’s disease and disease location. Inflamm. Bowel Dis. https://doi.org/10.1093/ibd/izab123 (2021). · DOI
  27. Yang, J., Dai, C. & Liu, Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J. Am. Soc. Nephrol. 16, 68–78 (2005). · DOI · Paper page
  28. Hudry-Clergeon, H., Stengel, D., Ninio, E. & Vilgrain, I. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3′-kinase. FASEB J. 19, 512–520 (2005). · DOI
  29. Meran, L., Baulies, A. & Li, V. S. W. Intestinal stem cell niche: the extracellular matrix and cellular components. Stem Cells Int. 2017, 7970385 (2017). · DOI · Paper page
  30. Sobhani, I. et al. Raised concentrations of platelet activating factor in colonic mucosa of Crohn’s disease patients. Gut 33, 1220–1225 (1992). · DOI
  31. Chakravarty, V. et al. Prolonged exposure to platelet activating factor transforms breast epithelial cells. Front. Genet. 12, 634938 (2021). · doi:10.3389/fgene.2021.634938
  32. Knezevic, I. I. et al. Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J. Biol. Chem. 284, 5381–5394 (2009). · DOI
  33. Jang, M. H. et al. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 176, 803–810 (2006). · DOI · Paper page
  34. Chamaillard, M. et al. Gene–environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl Acad. Sci. USA 100, 3455–3460 (2003). · DOI · Paper page
  35. Zhou, W. et al. Scalable generalized linear mixed model for region-based association tests in large biobanks and cohorts. Nat. Genet. 52, 634–639 (2020). · DOI · Paper page
  36. Pariente, B. et al. Treatments for Crohn’s disease-associated bowel damage: a systematic review. Clin. Gastroenterol. Hepatol. 17, 847–856 (2019). · DOI
  37. Festen, E. A. M. et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn’s disease and celiac disease. PLoS Genet. 7, e1001283 (2011). · DOI · Paper page
  38. Birkl, D. et al. TNFα promotes mucosal wound repair through enhanced platelet activating factor receptor signaling in the epithelium. Mucosal Immunol. 12, 909–918 (2019). · DOI
  39. Cromer, W. E., Mathis, J. M., Granger, D. N., Chaitanya, G. V. & Alexander, J. S. Role of the endothelium in inflammatory bowel diseases. World J. Gastroenterol. 17, 578–593 (2011). · DOI · Paper page
  40. Gommerman, J. L., Rojas, O. L. & Fritz, J. H. Re-thinking the functions of IgA+ plasma cells. Gut Microbes 5, 652–662 (2014). · DOI
  41. Stone, R. C. et al. Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell Tissue Res. 365, 495–506 (2016). · DOI · Paper page
  42. Fukushima, T., Uchiyama, S., Tanaka, H. & Kataoka, H. Hepatocyte growth factor activator: a proteinase linking tissue injury with repair. Int. J. Mol. Sci. 19, 3435 (2018). · DOI
  43. Waseda, M., Arimura, S., Shimura, E., Nakae, S. & Yamanashi, Y. Loss of Dok-1 and Dok-2 in mice causes severe experimental colitis accompanied by reduced expression of IL-17A and IL-22. Biochem. Biophys. Res. Commun. 478, 135–142 (2016). · DOI
  44. Cooke, J. et al. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm. Bowel Dis. 18, 2128–2137 (2012). · DOI
  45. Rhodes, J. Erythrocyte rosettes provide an analogue for Schiff base formation in specific T cell activation. J. Immunol. 145, 463–469 (1990). · doi:10.4049/jimmunol.145.2.463
  46. Celis-Gutierrez, J. et al. Dok1 and Dok2 proteins regulate natural killer cell development and function. EMBO J. 33, 1928–1940 (2014). · DOI
  47. Mucha, S. et al. Protein-coding variants contribute to the risk of atopic dermatitis and skin-specific gene expression. J. Allergy Clin. Immunol. 145, 1208–1218 (2020). · DOI · Paper page
  48. Tamehiro, N. et al. T-cell activation RhoGTPase-activating protein plays an important role in TH17-cell differentiation. Immunol. Cell Biol. 95, 729–735 (2017). · DOI
  49. Duke-Cohan, J. S. et al. Regulation of thymocyte trafficking by Tagap, a GAP domain protein linked to human autoimmunity. Sci. Signal. 11, eaan8799 (2018). · DOI
  50. Medrano, L. M. et al. Expression patterns common and unique to ulcerative colitis and celiac disease. Ann. Hum. Genet. 83, 86–94 (2019). · DOI
  51. Chen, J. et al. TAGAP instructs Th17 differentiation by bridging Dectin activation to EPHB2 signaling in innate antifungal response. Nat. Commun. 11, 1913 (2020). · DOI
  52. Clark, S. E. & Weiser, J. N. Microbial modulation of host immunity with the small molecule phosphorylcholine. Infect. Immun. 81, 392–401 (2013). · DOI
  53. Lv, X.-X. et al. Cigarette smoke promotes COPD by activating platelet-activating factor receptor and inducing neutrophil autophagic death in mice. Oncotarget 8, 74720–74735 (2017). · DOI
  54. Liu, G. et al. Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome. Mucosal Immunol. 12, 862–873 (2019). · DOI
  55. Ochoa, D. et al. Open Targets Platform: supporting systematic drug–target identification and prioritisation. Nucleic Acids Res. 49, D1302–D1310 (2020). · DOI · Paper page
  56. Blumert, C. et al. Analysis of the STAT3 interactome using in-situ biotinylation and SILAC. J. Proteomics 94, 370–386 (2013). · DOI
  57. Barrett, J. C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40, 955–962 (2008). · DOI · Paper page
  58. You, K. et al. QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis. Science 371, eabb6896 (2021). · DOI
  59. Fujimori, T. et al. Endoplasmic reticulum proteins SDF2 and SDF2L1 act as components of the BiP chaperone cycle to prevent protein aggregation. Genes Cells 22, 684–698 (2017). · DOI
  60. Meunier, L., Usherwood, Y.-K., Chung, K. T. & Hendershot, L. M. A subset of chaperones and folding enzymes form multiprotein complexes in endoplasmic reticulum to bind nascent proteins. Mol. Biol. Cell 13, 4456–4469 (2002). · DOI · Paper page
  61. Hanafusa, K., Wada, I. & Hosokawa, N. SDF2-like protein 1 (SDF2L1) regulates the endoplasmic reticulum localization and chaperone activity of ERdj3 protein. J. Biol. Chem. 294, 19335–19348 (2019). · DOI
  62. Sasako, T. et al. Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism. Nat. Commun. 10, 947 (2019). · DOI
  63. Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714–730.e22 (2019). · DOI · Paper page
  64. Autschbach, F., Funke, B., Katzenmeier, M. & Gassler, N. Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver—an immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens. Cell. Immunol. 236, 110–114 (2005). · doi:10.1016/j.cellimm.2005.08.016
  65. McNamee, E. N. et al. Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn’s-like murine ileitis. J. Leukoc. Biol. 97, 1011–1022 (2015). · DOI
  66. Murugan, D. et al. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J. Clin. Immunol. 34, 331–339 (2014). · DOI
  67. Pils, M. C. et al. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model. Eur. J. Immunol. 40, 443–448 (2010). · DOI
  68. Qu, X. et al. TLR4-RelA-miR-30a signal pathway regulates Th17 differentiation during experimental autoimmune encephalomyelitis development. J. Neuroinflammation 16, 183 (2019). · DOI
  69. Thompson, M. G. et al. FOXO3-NF-κB RelA protein complexes reduce proinflammatory cell signaling and function. J. Immunol. 195, 5637–5647 (2015). · DOI
  70. Badran, Y. R. et al. Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration. J. Exp. Med. 214, 1937–1947 (2017). · DOI
  71. Tian, B. et al. The NFκB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells. J. Biol. Chem. 293, 16528–16545 (2018). · DOI
  72. McCarroll, S. A. et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease. Nat. Genet. 40, 1107–1112 (2008). · DOI · Paper page
  73. Agrotis, A., Pengo, N., Burden, J. J. & Ketteler, R. Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells. Autophagy 15, 976–997 (2019). · DOI · Paper page
  74. Finisguerra, V. et al. MET is required for the recruitment of anti-tumoural neutrophils. Nature 522, 349–353 (2015). · DOI · Paper page
  75. Stakenborg, M. et al. Neutrophilic HGF-MET signaling exacerbates intestinal inflammation. J. Crohns Colitis https://doi.org/10.1093/ecco-jcc/jjaa121 (2020). · DOI
  76. Kanayama, M. et al. Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G230–G239 (2007). · DOI
  77. Tahara, Y. et al. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J. Pharmacol. Exp. Ther. 307, 146–151 (2003). · DOI
  78. Conomos, M. P., Reiner, A. P., Weir, B. S. & Thornton, T. A. Model-free estimation of recent genetic relatedness. Am. J. Hum. Genet. 98, 127–148 (2016). · DOI · Paper page
  79. Pasvol, T. J. et al. Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study. BMJ Open 10, e036584 (2020). · DOI
  80. Nakata, T. et al. A missense variant in SLC39A8 confers risk for Crohn’s disease by disrupting manganese homeostasis and intestinal barrier integrity. Proc. Natl Acad. Sci. USA 117, 28930–28938 (2020). · DOI
  81. Li, D. et al. A pleiotropic missense variant in SLC39A8 is associated with Crohn’s disease and human gut microbiome composition. Gastroenterology 151, 724–732 (2016). · DOI
  82. Sunuwar, L. et al. Pleiotropic ZIP8 A391T implicates abnormal manganese homeostasis in complex human disease. JCI Insight 5, e140978 (2020). · DOI
  83. Diogo, D. et al. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. PLoS ONE 10, e0122271 (2015). · DOI

Cited by

See all 194

Metadata

Authors
Sazonovs, A., Stevens, C. R., Venkataraman, G. R., Yuan, K., Avila, B., Abreu, M. T., Ahmad, T., Allez, M., Ananthakrishnan, A. N., Atzmon, G., Baras, A., Barrett, J. C., Barzilai, N., Beaugerie, L., Beecham, A., Bernstein, C. N., Bitton, A., Bokemeyer, B., Chan, A., Chung, D., Cleynen, I., Cosnes, J., Cutler, D. J., Daly, A., Damas, O. M., Datta, L. W., Dawany, N., Devoto, M., Dodge, S., Ellinghaus, E., Fachal, L., Farkkila, M., Faubion, W., Ferreira, M., Franchimont, D., Gabriel, S. B., Ge, T., Georges, M., Gettler, K., Giri, M., Glaser, B., Goerg, S., Goyette, P., Graham, D., Hämäläinen, E., Haritunians, T., Heap, G. A., Hiltunen, M., Hoeppner, M., Horowitz, J. E., Irving, P., Iyer, V., Jalas, C., Kelsen, J., Khalili, H., Kirschner, B. S., Kontula, K., Koskela, J. T., Kugathasan, S., Kupcinskas, J., Lamb, C. A., Laudes, M., Lévesque, C., Levine, A. P., Lewis, J. D., Liefferinckx, C., Loescher, B.-S., Louis, E., Mansfield, J., May, S., McCauley, J. L., Mengesha, E., Mni, M., Moayyedi, P., Moran, C. J., Newberry, R. D., O’Charoen, S., Okou, D. T., Oldenburg, B., Ostrer, H., Palotie, A., Paquette, J., Pekow, J., Peter, I., Pierik, M. J., Ponsioen, C. Y., Pontikos, N., Prescott, N., Pulver, A. E., Rahmouni, S., Rice, D. L., Saavalainen, P., Sands, B., Sartor, R. B., Schiff, E. R., Schreiber, S., Schumm, L. P., Segal, A. W., Seksik, P., Shawky, R., Sheikh, S. Z., Silverberg, M. S., Simmons, A., Skeiceviciene, J., Sokol, H., Solomonson, M., Somineni, H., Sun, D., Targan, S., Turner, D., Uhlig, H. H., van der Meulen, A. E., Vermeire, S., Verstockt, S., Voskuil, M. D., Winter, H. S., Young, J., Belgium IBD Consortium, Cedars-Sinai, I. B. D., International IBD Genetics Consortium, NIDDK IBD Genetics Consortium, BioResource, N. I., Regeneron Genetics Center, SHARE Consortium, SPARC IBD Network, UK IBD Genetics Consortium, Duerr, R. H., Franke, A., Brant, S. R., Cho, J., Weersma, R. K., Parkes, M., Xavier, R. J., Rivas, M. A., Rioux, J. D., McGovern, D. P. B., Huang, H., Anderson, C. A., & Daly, M. J.
Venue
Nature Genetics
Published
2022-08-29
Volume
54
Issue
9
Pages
1275-1283
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W4293475192
Cited by
194
References
12
FWCI
21.67
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (U54HG003067, 5UM1HG008895)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility. https://app.cochat.ai/papers/10.1038/s41588-022-01156-2
The paper
Sazonovs, A., Stevens, C. R., Venkataraman, G. R., Yuan, K., Avila, B., Abreu, M. T., Ahmad, T., Allez, M., Ananthakrishnan, A. N., Atzmon, G., Baras, A., Barrett, J. C., Barzilai, N., Beaugerie, L., Beecham, A., Bernstein, C. N., Bitton, A., Bokemeyer, B., Chan, A., . . . Daly, M. J. (2022). Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility. Nature Genetics. https://doi.org/10.1038/s41588-022-01156-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.